SEC Form 4 · accession 0001615774-17-007572
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernest Mario
Director
Period of report
Dec 14, 2017
Accepted (ET)
Dec 22, 2017 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1,F2 | Dec 14, 2017 | S | 1,967 | $3.58 | D | 55,467 | I | By Ernest and Mildred Mario Revocable Trust |
| Common Stock, $0.001 par valueF1,F3 | Dec 15, 2017 | S | 5,000 | $3.55 | D | 53,500 | I | By Ernest and Mildred Mario Revocable Trust |
| Common Stock, $0.001 par valueF1,F4 | Dec 18, 2017 | S | 10,000 | $3.57 | D | 43,500 | I | By Ernest and Mildred Mario Revocable Trust |
| Common Stock, $0.001 par valueF1,F5 | Dec 19, 2017 | S | 6,035 | $3.51 | D | 37,465 | I | By Ernest and Mildred Mario Revocable Trust |
| Common Stock, $0.001 par valueF1,F6 | Dec 20, 2017 | S | 8,965 | $3.44 | D | 28,500 | I | By Ernest and Mildred Mario Revocable Trust |
| Common Stock, $0.001 par valueF1,F7 | Dec 21, 2017 | S | 5,000 | $3.46 | D | 23,500 | I | By Ernest and Mildred Mario Revocable Trust |
| Common Stock, $0.001 par value | holding | — | — | — | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The volume weighted average purchase price of common stock sold by the reporting person in open market transactions on the transaction date. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- F2The range of sale prices on the transaction date was $3.530 to $3.610 per share.
- F3The range of sale prices on the transaction date was $3.520 to $3.650 per share.
- F4The range of sale prices on the transaction date was $3.510 to $3.605 per share.
- F5The range of sale prices on the transaction date was $3.458 to $3.571 per share.
- F6The range of sale prices on the transaction date was $3.400 to $3.510 per share.
- F7The range of sale prices on the transaction date was $3.410 to $3.500 per share.